Simon Couillard, MD-MSc
@simcouillard.bsky.social
Canadian respirologist • Collaborator / distinguished graduate, University of Oxford • Clinical researcher, Université de Sherbrooke.
Great response to our correspondence to Clarice Leung and John Fahy on the association between FeNO and baseline membrane thickness in SARP-3. This seems like a good marker of type-2 inflammation, and more specifically IL-13 activity, in #asthma.
www.atsjournals.org/doi/abs/10.1...
www.atsjournals.org/doi/abs/10.1...
July 4, 2025 at 12:21 PM
Great response to our correspondence to Clarice Leung and John Fahy on the association between FeNO and baseline membrane thickness in SARP-3. This seems like a good marker of type-2 inflammation, and more specifically IL-13 activity, in #asthma.
www.atsjournals.org/doi/abs/10.1...
www.atsjournals.org/doi/abs/10.1...
🚨 New paper in @lancetrespirmed.bsky.social !
ORACLE2: we pooled data from 6,500+ asthma patients x22 RCTs.
🧪 Blood eosinophils + FeNO = powerful predictors of asthma attacks (esp. together)
💨 Surprise: more lung reversibility = lower risk?
Open access 👉 doi.org/10.1016/S221...
Global collab 💪
ORACLE2: we pooled data from 6,500+ asthma patients x22 RCTs.
🧪 Blood eosinophils + FeNO = powerful predictors of asthma attacks (esp. together)
💨 Surprise: more lung reversibility = lower risk?
Open access 👉 doi.org/10.1016/S221...
Global collab 💪
April 9, 2025 at 1:39 AM
🚨 New paper in @lancetrespirmed.bsky.social !
ORACLE2: we pooled data from 6,500+ asthma patients x22 RCTs.
🧪 Blood eosinophils + FeNO = powerful predictors of asthma attacks (esp. together)
💨 Surprise: more lung reversibility = lower risk?
Open access 👉 doi.org/10.1016/S221...
Global collab 💪
ORACLE2: we pooled data from 6,500+ asthma patients x22 RCTs.
🧪 Blood eosinophils + FeNO = powerful predictors of asthma attacks (esp. together)
💨 Surprise: more lung reversibility = lower risk?
Open access 👉 doi.org/10.1016/S221...
Global collab 💪